Craig Johnson
Director/Board Member at TETRAPHASE PHARMACEUTICALS, INC.
Net worth: 167 841 $ as of 2024-04-29
Network origin in Craig Johnson first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Biotechnology | 47 | |
| Public Company | Biotechnology | 33 | |
| Subsidiary | Pharmaceuticals: Major | 27 | |
| Public Company | Pharmaceuticals: Major | 20 | |
TorreyPines Therapeutics, Inc.
 TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA.
15
| Extinct | Pharmaceuticals: Major | 15 |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE.
15
| Subsidiary | Pharmaceuticals: Major | 15 |
| Subsidiary | Pharmaceuticals: Major | 13 | |
| Subsidiary | Pharmaceuticals: Major | 9 | |
| Public Company | Pharmaceuticals: Major | 8 | |
TPTX, Inc.
6
| Extinct | Miscellaneous Commercial Services | 6 |
MitoKor, Inc.
 MitoKor, Inc. BiotechnologyHealth Technology MitoKor, Inc. provided discovery and diagnostic development of mitochondrial medicine. It was a biotechnology company focused on the research and development of drugs for the treatment of major diseases and conditions associated with mitochondrial dysfunction. The company was headquartered in San Diego, CA
3
| Extinct | Biotechnology | 3 |
Veracyte SD, Inc.
 Veracyte SD, Inc. Miscellaneous Commercial ServicesCommercial Services Decipher Biosciences, Inc. is a commercial-stage precision oncology company which engages in patient care improvement. The Company?s differentiated approach measures the biological activity of a patient?s entire tumor genome, known as whole transcriptome analysis, and applies proprietary machine learning algorithms to improve therapy selection and accelerate adoption of new therapies into the standard of care. Its novel prostate cancer genomic testing products examine the underlying biology of a patient?s tumor, enabling physicians to select an optimal therapy. The firm?s whole transcriptome analysis of clinical patient samples from its commercial channel and its participation in practice-changing clinical trials has allowed it to build and expand its Decipher GRID database GRID. The company was founded by Elai Davicioni, Timothy J. Triche, Bruce A. Schmidt, and Jonathan D. Buckley and is headquartered in San Diego, CA.
3
| Subsidiary | Miscellaneous Commercial Services | 3 |
The University of Michigan-Dearborn
3
| College/University | Other Consumer Services | 3 |
Raptor Pharmaceuticals Corp.
 Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007.
3
| Extinct | Pharmaceuticals: Major | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Craig Johnson via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Comptroller/Controller/Auditor Chief Tech/Sci/R&D Officer Founder Director of Finance/CFO Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal General Counsel General Counsel Corporate Officer/Principal Compliance Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Sales & Marketing Chief Tech/Sci/R&D Officer General Counsel | |
| KARA THER | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director/Board Member President | |
| University of California, Berkeley | College/University | Doctorate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
| SPECTRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| RAYZEBIO, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal Director/Board Member Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| COLLEGIUM PHARMACEUTICAL, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Sales & Marketing | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of Illinois | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| MONOPAR THERAPEUTICS INC. | Biotechnology | Director of Finance/CFO Founder Director/Board Member | |
| TURG POIN | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Chairman Investor Relations Contact Director/Board Member | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| University of California, Santa Barbara | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| ENTASIS THERAPEUTICS HOLDINGS INC. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Graduate Degree Masters Business Admin | |
| University of San Diego | College/University | Undergraduate Degree Undergraduate Degree Director/Board Member | |
| Stanford University | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
| ANAPTYSBIO, INC. | Biotechnology | Director of Finance/CFO Chairman Chief Executive Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| REVELATION BIOSCIENCES, INC. | Biotechnology | Chairman Director/Board Member Investor Relations Contact | |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Pharmaceuticals: Major | General Counsel Founder Corporate Officer/Principal | |
Revelation Biosciences Sub, Inc.
 Revelation Biosciences Sub, Inc. Medical SpecialtiesHealth Technology Part of Revelation Biosciences, Inc., Revelation Biosciences Sub, Inc. develops medical devices. The private company is based in San Diego, CA. James M. Rolke has been the CEO of the company since 2020. Revelation Biosciences Sub was acquired by Petra Acquisition, Inc. on January 11, 2022 for $87.36 million. | Medical Specialties | Chairman Director/Board Member | |
| IMMUNE DESIGN CORP | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Masters Business Admin | |
| CELGENE | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
CovX Research LLC
 CovX Research LLC BiotechnologyHealth Technology Part of Pfizer Inc., CovX Research LLC is a private company that manufactures biotherapeutics and medical products. The company is based in San Diego, CA. The company was founded by Richard Alan Lerner, Carlos F. Barbas. CovX Research was acquired by Pfizer Inc. from Tavistock Life Sciences Co. on January 31, 2008 for $230 million. | Biotechnology | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Doctorate Degree | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Comptroller/Controller/Auditor | |
Nucleus Biologics LLC
 Nucleus Biologics LLC BiotechnologyHealth Technology Nucleus Biologics LLC develops cellular immunotherapies. Its products include PhysiologixTM XF SR, Vitronectin XF, Australia and New Zealand Origin FBS and zIsletTM media. The firm offers complete media manufacturing services. The company was founded in 2016 and is headquartered in San Diego, CA. | Biotechnology | Chairman Director/Board Member | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Pharmaceuticals: Major | Director/Board Member Comptroller/Controller/Auditor | |
Seragon Pharmaceuticals, Inc.
 Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistics
International
| United States | 50 |
| Ireland | 2 |
Sectoral
| Health Technology | 38 |
| Consumer Services | 12 |
| Finance | 2 |
| Commercial Services | 2 |
Operational
| Director/Board Member | 535 |
| Corporate Officer/Principal | 260 |
| Independent Dir/Board Member | 188 |
| Chairman | 125 |
| Chief Executive Officer | 104 |
Most connected contacts
| Insiders | |
|---|---|
| Carol Gallagher | 39 |
| John Freund | 37 |
| William Ringo | 32 |
| Michael Grey | 32 |
| Julie Cherrington | 32 |
| Llew Keltner | 32 |
| Walter Moos | 30 |
| Tina Nova | 29 |
| Felix Baker | 28 |
| Patrick van Beneden | 28 |
| Faheem Hasnain | 27 |
| Leonard Patrick Gage | 26 |
| Wendy Dixon | 25 |
| Bruce Carter | 25 |
| Neil Reisman | 23 |
- Stock Market
- Insiders
- Craig Johnson
- Company connections
